A double-digit growth rate through 2024 means boom times for drug-delivery devices and for contract manufacturing services
Payal Kulkarni, Grand View Research
Advertisement
Articles by Payal Kulkarni, Grand View Research
Advertisement
Latest Updated Articles
- Vaccine growth spurs device, contract-services markets
Published: June 25th 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Lupin Invests $250 Million in New Coral Springs Manufacturing Facility to Bolster US Respiratory Drug Supply
2
Pharma Pulse: Mark Cuban Disrupts Drug Pricing, AstraZeneca Expands US Manufacturing, and BMS Bets Big on RNA Therapeutics
3
